Viciani, Elisa
Montagnani, Francesca
Tavarini, Simona
Tordini, Giacinta
Maccari, Silvia
Morandi, Matteo
Faenzi, Elisa
Biagini, Cesare
Romano, Antonio
Salerni, Lorenzo
Finco, Oretta
Lazzi, Stefano
Ruggiero, Paolo
De Luca, Andrea
Barocchi, Michèle A.
Manetti, Andrea G. O.
Article History
Received: 22 July 2015
Accepted: 8 January 2016
First Online: 10 February 2016
Competing interests
: ADL has a personal fee from Merck Sharp and Dohme, ADL, MF, LS, AR and CB have done contract research for Novartis Vaccine and Diagnostics S.r.l. on behalf of the Hospital University of Siena, Italy. SL has acted as a consultant for Novartis Vaccine and Diagnostics S.r.l. on behalf of the Hospital University of Siena, Italy. MAB holds Novartis Vaccine and Diagnostics S.r.l. stock options. EF, SM, ST, OF, PR, MAB and AGOM are employees of Novartis Vaccine and Diagnostics S.r.l., who, working to develop an effective vaccine against GAS infection, has produced a family of pending or issued patents, regarding SLO mutant vaccine antigen listed below: PI0821240-6; 2709927; 200880126781.1; EP2235046; 12178329.4; 2339/KOLNP/2010; 2010-538946; 2013-211628; 10-2010-7016353; 292215; 586430; 601543; 2010130338; 163666; 8039005; 8409589 and 7731978. Furthermore, AGOM is among authors of the following Novartis Vaccine and Diagnostics patents regarding SLO protein: 2009334428 issued, a patent 2013203063 pending, a patent PI0919236-0 pending, a patent 2737453 pending, a patent 200980142304.9 pending, a patent 09786278.3 pending, a patent 12100678.5 pending, a patent 1427/KOLNP/2011 pending, a patent 2011-527423 pending, a patent MX/a/2011/002760 issued, a patent 591633 issued, a patent 12/561619 pending, and a patent 2011/02005 pending. EV has been recipient of a Novartis Vaccine and Diagnostics S.r.l. Fellowship from the PhD program of the University of Siena.